Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison

Published:2016-04-04 Issue:6 Volume:56 Page:1394-1401
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Valtola Jaakko¹,Silvennoinen Raija²,Ropponen Antti³,Siitonen Timo⁴,Säily Marjaana⁴,Sankelo Marja⁵,Terävä Venla⁵,Putkonen Mervi⁶,Kuittinen Taru⁷,Pelkonen Jukka³⁸,Mäntymaa Pentti⁸,Remes Kari⁶⁹,Varmavuo Ville¹,Jantunen Esa¹

Affiliation:

1. Department of Medicine; Kuopio University Hospital; Kuopio Finland

2. Comprehensive Cancer Center; Helsinki University Hospital; Helsinki Finland

3. Department of Clinical Microbiology; University of Eastern Finland; Kuopio Finland

4. Department of Medicine; Oulu University Hospital; Oulu Finland

5. Department of Internal Medicine; Tampere University Hospital; Tampere Finland

6. Department of Medicine; Turku University Hospital; Turku Finland

7. Finnish Medicines Agency

8. Laboratory Center of Eastern Finland; Kuopio Finland

9. University of Turku; Turku Finland

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13574/fullpdf

Reference39 articles.

1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome;Attal;N Engl J Med,1996

2. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

3. International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100);Giralt;Leukemia,2009

4. Mutiple myeloma;Röllig;Lancet,2015

5. Autologous transplantation for multiple myeloma in the era of new drugs: a phase III study of the Intergroupe Francophone du Myelome (IFM/DFCI 2009 Trial) [abstract];Attal;Blood,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments;Annals of Hematology;2023-03-22

2. Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation;Transfusion Medicine and Hemotherapy;2023

3. Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials;Stem Cell Research & Therapy;2022-03-22

4. Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation;International Journal of Hematology;2021-07-02

5. Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study;Transfusion;2021-05-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3